ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 14 Nov 2022
Last Updated on 14 Nov 2022
A- A+
Guidance Recommendation

The Ministry of Health’s Medical Technology Advisory Committee has not recommended subsidy for robot-assisted endovascular intervention systems for coronary artery disease (CAD) and other vascular diseases.

Funding status

Robot-assisted endovascular intervention systems are not recommended for subsidy in patients with the abovementioned indications.


Robot-assisted endovascular intervention systems for CAD and other vascular diseases